ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Arix Bioscience plc: Team changes
July 07, 2021Arix Bioscience plc (“Arix” or “the Company”) (LSE: ARIX), a global venture capital company focused on investing and building breakthrough biotech companies, today announces that Mark Chin will be re-joining the Arix investment team as a Managing Director -
Harpoon Therapeutics Granted Orphan Drug Designation for Multiple Myeloma Treatment
January 20, 2021Harpoon Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for HPN217 for the treatment of multiple myeloma. HPN217, a tri-specific T cell activating recombinant protein construct (TriTAC®) targets ... -
Harpoon and Gossamer sneak out IPOs before potential SEC shutdown
February 15, 2019Immunotherapy specialist Harpoon Therapeutics has joined a group of biotechs that have sneaked out IPOs before another potential US government shutdown this weekend that could prevent further listings. -
Harpoon files $86M IPO to help fund its T-cell engager platform
January 04, 2019Fresh off raising $70 million through a series C round just over a month ago, Harpoon Therapeutics announced it will go public with an $86.25 million IPO to further support its portfolio of early-stage T-cell engagers aimed at solid tumors.....
Pharma Sources Insight January 2025
